Reply: Intravenous tocilizumab in the treatment of resistant optic perineuritis: a case report. Maleki A, Fernandez CC, Foster CS. Can J Ophthalmol 2022;57:284-286.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Maleki A, Fernandez CC, Foster CS. Reply: Intravenous tocilizumab in the treatment of resistant optic perineuritis: a case report. Can J Ophthalmol 2022;57:284-286.
PMID: 35283105